Disease Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

ID DOID:60073
Name lymphatic system cancer
Definition An immune system cancer that is located_in the lymphatic system and is characterized by uncontrolled cellular proliferation of lymphoid tissue.
Source DiseaseOntology.org
Alt Ids
Path disease disease of cellular proliferation cancer organ system cancer immune system cancer lymphatic system cancer

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Molecular Profile Therapy Indication/Tumor Type Response Type Profile Response Detail
MAP2K1 K57N Trametinib lymphatic system cancer sensitive detail...
MAP2K1 Q56P Cobimetinib lymphatic system cancer predicted - sensitive detail...
Unknown unknown Cobimetinib lymphatic system cancer not applicable detail...
BRAF V600E Cobimetinib lymphatic system cancer predicted - sensitive detail...
BRAF N486_T491delinsK Cobimetinib lymphatic system cancer predicted - sensitive detail...
MAP2K1 P124L Cobimetinib lymphatic system cancer predicted - sensitive detail...
MAP2K1 P124Q Cobimetinib lymphatic system cancer predicted - sensitive detail...
MAP2K1 P105_I107del Cobimetinib lymphatic system cancer predicted - sensitive detail...
Clinical Trial Phase Therapies Title Recruitment Status
NCT03155620 Phase II Tazemetostat Larotrectinib LY3023414 Vemurafenib Palbociclib Olaparib Ulixertinib Erdafitinib Selumetinib Ensartinib Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) Recruiting